REGENERON PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - February 8, 2021

Attached files

file filename
EX-10.34.1 - MODIFICATION 01 TO PROJECT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ATI - REGENERON PHARMACEUTICALS, INC.regn-ex_10341x12312020x10k.htm
EX-32 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - REGENERON PHARMACEUTICALS, INC.regn-ex_32x12312020x10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.regn-ex_312x12312020x10k.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.regn-ex_311x12312020x10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - REGENERON PHARMACEUTICALS, INC.regn-ex_211x12312020x10k.htm
EX-10.34.2 - MODIFICATION 02 TO PROJECT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ATI - REGENERON PHARMACEUTICALS, INC.regn-ex_10342x12312020x10k.htm
EX-10.34 - PROJECT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ATI - REGENERON PHARMACEUTICALS, INC.regn_exx1034-12312020x10k.htm
EX-10.3.7 - PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT - REGENERON PHARMACEUTICALS, INC.regn-ex_1037x12312020x10k.htm
EX-10.3.6 - RESTRICTED STOCK AGREEMENT - NON-EMPLOYEE DIRECTORS - REGENERON PHARMACEUTICALS, INC.regn-ex_1036x12312020x10k.htm
EX-10.3.5 - STOCK OPTION AGREEMENT (NQ) - NON-EMPLOYEE DIRECTORS - REGENERON PHARMACEUTICALS, INC.regn-ex_1035x12312020x10k.htm
EX-10.3.4 - RESTRICTED STOCK AGREEMENT - P. ROY VAGELOS - REGENERON PHARMACEUTICALS, INC.regn-ex_1034x12312020x10k.htm
EX-10.3.3 - RESTRICTED STOCK AGREEMENT - EXECUTIVE OFFICERS - REGENERON PHARMACEUTICALS, INC.regn-ex_1033x12312020x10k.htm
EX-10.3.2 - STOCK OPTION AGREEMENT (NQ) - P. ROY VAGELOS - REGENERON PHARMACEUTICALS, INC.regn-ex_1032x12312020x10k.htm
EX-10.3.1 - STOCK OPTION AGREEMENT (NQ) - EXECUTIVE OFFICERS - REGENERON PHARMACEUTICALS, INC.regn-ex_1031x12312020x10k.htm
10-K - 10-K - REGENERON PHARMACEUTICALS, INC.regn-20201231.htm

Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-228352) and S‑8 (Nos. 333-61132, 333-97375, 333-119257, 333-151941, 333-169569, 333-174863, 333-196799, 333-198794, 333-218669, and 333-239209) of Regeneron Pharmaceuticals, Inc., of our report dated February 8, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.


/s/ PricewaterhouseCoopers LLP

Florham Park, New Jersey
February 8, 2021



REGENERON PHARMACEUTICALS, INC. Reports